Concepedia

Sergio Parra

SP

16

Publications

989

Citations

14

H-Index

2007

Active since

Affiliations

University of Houston(Current)

Florida International University

University of Michigan

University of Washington

The University of Texas MD Anderson Cancer Center

Sergio Parra is an author at University of Houston specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2007–2023

16

Publications

16

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19

Anil Kumar Gupta, Yaneicy Gonzalez‐Rojas, Erick Stanley Petersen Juárez et al. · JAMA · 2022 · 288 citations · Full text

Chronic Exposure to Beta-Blockers Attenuates Inflammation and Mucin Content in a Murine Asthma Model

Long Nguyễn, Ozozoma Omoluabi, Sergio Parra et al. · American Journal of Respiratory Cell and Molecular Biology · 2007 · 137 citations · Full text

, , +15

The safety and effects of the beta-blocker, nadolol, in mild asthma: An open-label pilot study

Nicola A. Hanania, Supria Singh, Rami El-Wali et al. · Pulmonary Pharmacology & Therapeutics · 2007 · 131 citations · Full text

, , +6

β <sub>2</sub> -Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model

Long Nguyễn, Rui Lin, Sergio Parra et al. · Proceedings of the National Academy of Sciences · 2009 · 104 citations · Full text

Changes in β2-adrenoceptor and other signaling proteins produced by chronic administration of ‘β-blockers’ in a murine asthma model

Rui Lin, Hui Peng, Long Nguyễn et al. · Pulmonary Pharmacology & Therapeutics · 2007 · 74 citations · Full text

, , +13

Rows per page

1–5 of 16